Cinnamaldehyde: a new treatment of benign prostatic hyperplasia medicine
Benign prostatic hyperplasia (BPH) is the area around the urethra, the prostate cells, benign adenomatous hyperplasia, studies have shown that patients with the body of a substance known as DHT is the main incentive for BPH. In older men, BPH is a common disease, clinical statistics show during 40 to 79 years old , benign prostatic hyperplasia incidence
Currently, the clinical treatment of benign prostatic hyperplasia is the main methods used to wait for vigilance, surgery and drug therapy. Because drug treatment has the advantage of safe, convenient, painless and so on , clinical control and therefore the best choice for the treatment of BPH. Currently there are drugs for BPH-blockers, these drugs are exported through the expansion of the bladder and prostate smooth muscle to relieve symptoms. However, these drugs can reduce prostate size, is also no information can prevent its long-term complications. There is a 5α-reductase inhibitors, such drugs on behalf of the product is finasteride, which can effectively reduce prostate size, but the drug finasteride is a long time, usually after 6 months continuous treatment until cured, this will greatly increase the financial burden of patients.
For this, medical experts have found that the use of cinnamic aldehyde as the raw material can be prepared a significant effect of BPH treatments. After further research, experts say this new drug with the conditions of industrial production, then, cinnamaldehyde may be able to become a new medicine for the treatment of BPH.